GLP-1 drugs may reduce the risk of cancer progressing, study suggests

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.
Source
NBC News
Opens original article in a new tab



